Found: 164
Select item for more details and to access through your institution.
The synthetic heat shock protein 90 (Hsp90) inhibitor EC141 induces degradation of Bcr-Abl p190 protein and apoptosis of Ph-positive acute lymphoblastic leukemia cells.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 6, p. 1206, doi. 10.1007/s10637-010-9465-8
- By:
- Publication type:
- Article
Preclinical characterization of atiprimod, a novel JAK2 AND JAK3 inhibitor.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 5, p. 818, doi. 10.1007/s10637-010-9429-z
- By:
- Publication type:
- Article
Kit inhibitor APcK110 extends survival in an AML xenograft mouse model.
- Published in:
- 2011
- By:
- Publication type:
- Report
TP53‐altered chronic lymphocytic leukemia treated with firstline Bruton's tyrosine kinase inhibitor‐based therapy: A retrospective analysis.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 8, p. 1005, doi. 10.1002/ajh.26595
- By:
- Publication type:
- Article
Long‐term results of low‐intensity chemotherapy with clofarabine or cladribine combined with low‐dose cytarabine alternating with decitabine in older patients with newly diagnosed acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 8, p. 914, doi. 10.1002/ajh.26206
- By:
- Publication type:
- Article
Clinical outcomes and influence of mutation clonal dominance in oligomonocytic and classical chronic myelomonocytic leukemia.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 2, p. E50, doi. 10.1002/ajh.26044
- By:
- Publication type:
- Article
Phase I/II study of dasatinib in combination with decitabine in patients with accelerated or blast phase chronic myeloid leukemia.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 11, p. 1288, doi. 10.1002/ajh.25939
- By:
- Publication type:
- Article
Phase 2 study of hyper‐CMAD with liposomal vincristine for patients with newly diagnosed acute lymphoblastic leukemia.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 7, p. 734, doi. 10.1002/ajh.25784
- By:
- Publication type:
- Article
The early achievement of measurable residual disease negativity in the treatment of adults with Philadelphia‐negative B‐cell acute lymphoblastic leukemia is a strong predictor for survival.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 2, p. 144, doi. 10.1002/ajh.25671
- By:
- Publication type:
- Article
A phase II study of omacetaxine mepesuccinate for patients with higher‐risk myelodysplastic syndrome and chronic myelomonocytic leukemia after failure of hypomethylating agents.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 1, p. 74, doi. 10.1002/ajh.25318
- By:
- Publication type:
- Article
Biclonal IGHV‐4‐34 hairy cell leukemia variant and CLL ‐ successful treatment with ibrutinib and venetoclax.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 12, p. 1568, doi. 10.1002/ajh.25264
- By:
- Publication type:
- Article
Sorafenib Combined with 5‐azacytidine in Older Patients with Untreated FLT3‐ITD Mutated Acute Myeloid Leukemia.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 9, p. 1136, doi. 10.1002/ajh.25198
- By:
- Publication type:
- Article
A phase II trial of ruxolitinib in combination with azacytidine in myelodysplastic syndrome/myeloproliferative neoplasms.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 2, p. 277, doi. 10.1002/ajh.24972
- By:
- Publication type:
- Article
Clinical characteristics and outcomes of previously untreated patients with adult onset T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma with hyper-CVAD based regimens.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 10, p. E595, doi. 10.1002/ajh.24833
- By:
- Publication type:
- Article
Factors associated with risk of central nervous system relapse in patients with non-core binding factor acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 9, p. 924, doi. 10.1002/ajh.24799
- By:
- Publication type:
- Article
Natural history of chronic myelomonocytic leukemia treated with hypomethylating agents.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 7, p. 599, doi. 10.1002/ajh.24735
- By:
- Publication type:
- Article
An exploratory clinical trial of bortezomib in patients with lower risk myelodysplastic syndromes.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 7, p. 674, doi. 10.1002/ajh.24746
- By:
- Publication type:
- Article
Outcomes of adults with relapsed or refractory Burkitt and high-grade B-cell leukemia/lymphoma.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 6, p. E114, doi. 10.1002/ajh.24720
- By:
- Publication type:
- Article
PET-positive lymphadenopathy in CLL-Not always Richter transformation.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 4, p. 405, doi. 10.1002/ajh.24566
- By:
- Publication type:
- Article
Impact of achievement of complete cytogenetic response on outcome in patients with myelodysplastic syndromes treated with hypomethylating agents.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 4, p. 351, doi. 10.1002/ajh.24650
- By:
- Publication type:
- Article
Clinical and molecular characteristics of XPO1 mutations in patients with chronic lymphocytic leukemia.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 11, p. E478, doi. 10.1002/ajh.24496
- By:
- Publication type:
- Article
Philadelphia-positive dimorphic blasts in mixed-phenotype acute leukemia with TET2 mutation.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 6, p. 647, doi. 10.1002/ajh.24295
- By:
- Publication type:
- Article
Synchronous del5q myelodysplastic syndrome (del5qMDS) and adult B-cell acute lymphoblastic leukemia (B-ALL) with TET2 and TP53 mutations.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 3, p. 354, doi. 10.1002/ajh.24208
- By:
- Publication type:
- Article
Durable remission with rituximab in a patient with an unusual variant of Castleman's disease with myelofibrosis- TAFRO syndrome.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 11, p. 1091, doi. 10.1002/ajh.24015
- By:
- Publication type:
- Article
Disseminated histoplasmosis as pseudo Richter's transformation in a patient with chronic lymphocytic leukemia.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 8, p. 752, doi. 10.1002/ajh.24029
- By:
- Publication type:
- Article
High fluorescence in situ hybridization percentage of deletion 11q in patients with chronic lymphocytic leukemia is an independent predictor of adverse outcome.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 6, p. 471, doi. 10.1002/ajh.23978
- By:
- Publication type:
- Article
Phase I/II trial of the combination of midostaurin (PKC412) and 5-azacytidine for patients with acute myeloid leukemia and myelodysplastic syndrome.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 4, p. 276, doi. 10.1002/ajh.23924
- By:
- Publication type:
- Article
Phase II study of methotrexate, vincristine, pegylated-asparaginase, and dexamethasone ( MOp AD) in patients with relapsed/refractory acute lymphoblastic leukemia.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 2, p. 120, doi. 10.1002/ajh.23886
- By:
- Publication type:
- Article
Clofarabine, idarubicin, and cytarabine (CIA) as frontline therapy for patients ≤60 years with newly diagnosed acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 11, p. 961, doi. 10.1002/ajh.23544
- By:
- Publication type:
- Article
Acquisition of cytogenetic abnormalities in patients with IPSS defined lower-risk myelodysplastic syndrome is associated with poor prognosis and transformation to acute myelogenous leukemia.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 10, p. 831, doi. 10.1002/ajh.23513
- By:
- Publication type:
- Article
Prognostic impact of RAS mutations in patients with myelodysplastic syndrome.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 5, p. 365, doi. 10.1002/ajh.23410
- By:
- Publication type:
- Article
Phase II study of the histone deacetylase inhibitor panobinostat (LBH589) in patients with low or intermediate-1 risk myelodysplastic syndrome.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 1, p. 127, doi. 10.1002/ajh.22198
- By:
- Publication type:
- Article
Lymphocytic variant of hypereosinophilic syndrome: A report of seven cases from a single institution.
- Published in:
- Cytometry. Part B, 2021, v. 100, n. 3, p. 352, doi. 10.1002/cyto.b.21874
- By:
- Publication type:
- Article
Isavuconazole as Primary Antifungal Prophylaxis in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome: An Open-label, Prospective, Phase 2 Study.
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 10, p. 1755, doi. 10.1093/cid/ciaa358
- By:
- Publication type:
- Article
Stem Cells and Somatic Cells: Reprogramming and Plasticity.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, p. S319, doi. 10.3816/CLM.2009.s.031
- By:
- Publication type:
- Article
Why Is the Immunoglobulin Heavy Chain Gene Mutation Status a Prognostic Indicator in Chronic Lymphocytic Leukemia?
- Published in:
- Acta Haematologica, 2018, v. 140, n. 1, p. 51, doi. 10.1159/000491382
- By:
- Publication type:
- Article
A Pilot Phase II Study of Erlotinib for the Treatment of Patients with Relapsed/Refractory Acute Myeloid Leukemia.
- Published in:
- Acta Haematologica, 2018, v. 140, n. 1, p. 30, doi. 10.1159/000490092
- By:
- Publication type:
- Article
Circulating Mononuclear Cells from Pure Red Cell Aplasia of Chronic Lymphocytic Leukemia Suppress in vitro Erythropoiesis.
- Published in:
- Acta Haematologica, 1989, v. 81, n. 4, p. 213, doi. 10.1159/000205564
- By:
- Publication type:
- Article
Circulating Endothelial Progenitor Cells and Coronary Collaterals in Patients with Non-ST Segment Elevation Myocardial Infarction.
- Published in:
- Journal of Vascular Research, 2005, v. 42, n. 5, p. 408, doi. 10.1159/000087370
- By:
- Publication type:
- Article
Complex biallelic IGH rearrangements in IgM-expressing Z-138 cell line: Involvement of downstream immunoglobulin class switch recombination.
- Published in:
- Genes, Chromosomes & Cancer, 2005, v. 42, n. 2, p. 164, doi. 10.1002/gcc.20132
- By:
- Publication type:
- Article
Clinical utility of marrow cell tissue cultures in acute leukemia of childhood.
- Published in:
- American Journal of Hematology, 1986, v. 23, n. 1, p. 51, doi. 10.1002/ajh.2830230108
- By:
- Publication type:
- Article
Heterodimeric JAK-STAT activation as a mechanism of persistence to JAK2 inhibitor therapy.
- Published in:
- Nature, 2012, v. 489, n. 7414, p. 155, doi. 10.1038/nature11303
- By:
- Publication type:
- Article
Mutant FLT3: A Direct Target of Sorafenib in Acute Myelogenous Leukemia.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2008, v. 100, n. 3, p. 184, doi. 10.1093/jnci/djm328
- By:
- Publication type:
- Article
OSW-1: a Natural Compound With Potent Anticancer Activity and a Novel Mechanism of Action.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 23, p. 1781, doi. 10.1093/jnci/dji404
- By:
- Publication type:
- Article
2121. Isavuconazole (ISAV) as Primary Anti-Fungal Prophylaxis (PAP) in Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS): An Open-Label, Prospective Study.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S718, doi. 10.1093/ofid/ofz360.1801
- By:
- Publication type:
- Article
The cXcr4-sTaT3-il-10 Pathway controls the immunoregulatory Function of chronic lymphocytic leukemia and is Modulated by lenalidomide.
- Published in:
- Frontiers in Immunology, 2018, p. 1, doi. 10.3389/fimmu.2017.01773
- By:
- Publication type:
- Article
Leukemia-inhibitory factor stimulates breast, kidney and prostate cancer cell proliferation by paracrine and autocrine pathways.
- Published in:
- International Journal of Cancer, 1996, v. 66, n. 4, p. 515, doi. 10.1002/(SICI)1097-0215(19960516)66:4<515::AID-IJC15>3.0.CO;2-6
- By:
- Publication type:
- Article
MPN-383: GLI1 Promotes the Pro-Fibrotic Function of Monocyte-Derived Fibrocytes in Myelofibrosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S365, doi. 10.1016/S2152-2650(21)01838-3
- By:
- Publication type:
- Article
MPN-314: Improved Survival of Patients with Primary Myelofibrosis in the Last Decade at a Large Single Academic Center.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S361, doi. 10.1016/S2152-2650(21)01831-0
- By:
- Publication type:
- Article
CLL-348: STAT3 Induces the Expression of GLI1 in Chronic Lymphocytic Leukemia Cells.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S322, doi. 10.1016/S2152-2650(21)01759-6
- By:
- Publication type:
- Article